Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
PRODUCTION OF HUMAN IGF BY RECOMBINANT DNA TECHNIQUE
Document Type and Number:
Japanese Patent JPH0759578
Kind Code:
A
Abstract:

PURPOSE: To obtain an expression vector capable of expressing a DNA sequence encoding human insulin-like growth factor in a transformed recombinant bacterial host, and capable of producing the subject material useful for treatment or the like for the symptom affecting the growth by a recombinant DNA technique.

CONSTITUTION: This method for efficiently producing a matured protein of a human IGF by a recombinant DNA technique comprises a step for recovering pBR322 plasmid containing a promoter region and derived from Escherichia coli or the like as a vector capable of being expressed in a prokaryotic cell, a step for treating the pBR322 plasmid with a restriction enzyme, a step for incorporating a DNA encoding human insulin-like growth factor(IGF) to prepare a recombinant plasmid containing the human IGF gene, a step for inserting the recombinant plasmid into a transformed recombinant prokaryotic host such as E. coli-K12 strain 294 (ATCC No.31446) to transform the host, and a step for culturing the transformant by the expression vector capable of expressing a DNA sequence encoding the human IGF in the prokaryotic host.


Inventors:
LEE JAMES MON (US)
ULLRICH AXEL (DE)
Application Number:
JP12649694A
Publication Date:
March 07, 1995
Filing Date:
June 08, 1994
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
GENENTECH INC (US)
International Classes:
A61K35/74; A61K38/00; A61K38/28; C07H21/04; C07K14/485; C07K14/65; C12N1/18; C12N1/19; C12N1/20; C12N1/21; C12N9/26; C12N15/00; C12N15/09; C12N15/81; C12P21/00; C12P21/02; C12R1/19; C12R1/865; (IPC1-7): C12N15/09; C12N1/21
Other References:
J.BIOL.CHEM.=1978
PROC NATL ACAD SCI USA=1981
PROC NATL ACAD SCI USA=1979
Attorney, Agent or Firm:
Aoyama Ryo (1 person outside)